TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN

Agonists for TLR9 and Stimulator of IFN Gene (STING) act as vaccine adjuvants that induce type-1 immune responses. However, currently available CpG oligodeoxynucleotide (ODN) (K-type) induces IFNs only weakly and STING ligands rather induce type-2 immune responses, limiting their potential therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales: Temizoz, Burcu, Kuroda, Etsushi, Ohata, Keiichi, Jounai, Nao, Ozasa, Koji, Kobiyama, Kouji, Aoshi, Taiki, Ishii, Ken J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Innate Immunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671267/
https://www.ncbi.nlm.nih.gov/pubmed/25529558
http://dx.doi.org/10.1002/eji.201445132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671267/
https://www.ncbi.nlm.nih.gov/pubmed/25529558
http://dx.doi.org/10.1002/eji.201445132

Ejemplares similares